Live Breaking News & Updates on Other Notable Investors In Alnylam Pharmaceuticals

On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its investment portfolio by reducing its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY). The transaction involved the sale of 1,196,042 shares, which resulted in a 14.65% decrease in Baillie Gifford (Trades, Portfolio)'s holdings in the company. ....

Alnylam Pharmaceuticals , Other Notable Investors In Alnylam Pharmaceuticals , Alnylam Pharmaceutical , Jefferies Group , Vanguard Health Care Fund , Financial Health Of Alnylam Pharmaceuticals , Baillie Gifford , Growth Rank , Financial Strength , Profitability Ranks , Consumer Cyclical , Notable Investors , Health Care Fund , Joel Greenblatt , Alnylam Pharmaceuticals , Nvestment Management Firm , Investment Portfolio , Biotech Company ,